According to a new report Global Digital Pathology Market, published by KBV research, The Global Digital Pathology Market size is expected to reach $1.4 billion by 2026, rising at a market growth of 6.2% CAGR during the forecast period.
The rising usage of scanners in pathology labs is expected to fuel the growth of the market. Along with that, the growing R&D related to applications like slide managers and the rising demand for online storage systems are estimated to increase the adoption of the technology over the forecast period.
Moreover, the benefits offered by these solutions like cost reduction, enhanced technology, and improved patient outcomes along with data reliability and Image Lifecycle Management are anticipated to support the growth of the market.
Based on application, the academic research category is gained increase in revenue share of the market in 2019. It is due to the broad applications of these systems in different research processes like biomarker profiling and tumor morphological study. The cancer cell detection market segment would exhibit promising growth rate in the disease diagnosis segment during the forecast period, due to the increasing rates of the disease along with continuous research initiatives.
The digital pathology market would develop with a major growth rate in the Asia-Pacific region over the forecast period. This growth is attributed to the increasing penetration of digital imaging in developing nations, investments in the medical field, and the presence of unexplored opportunities.
Asia Pacific healthcare sector has incredibly driven the market, owing to the growing incidence of cancer that impacts a major population. Apart from that, the rising demand for novel treatment options improved patient care facilities and decreased laboratory expenses, thereby expected to fuel the demand for the digital pathology market during the forecast period.
Full Report: https://www.kbvresearch.com/digital-pathology-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Danaher Corporation (Leica Biosystems), Koninklijke Philips N.V., Olympus Corporation, F. Hoffmann-La Roche Ltd., ContextVision AB, Hamamatsu Photonics K.K., Mikroscan Technologies, Inc., Inspirata, Inc., Visiopharm A/S, and 3DHISTECH Ltd.
Global Digital Pathology Market Segmentation
By Product
- Device
- Software
- Storage System
By End Use
- Hospitals
- Diagnostic Labs
- Biotech & pharma companies
- Academic & research institutes
By Application
- Drug Discovery & Development
- Disease Diagnosis
- Academic research
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- Danaher Corporation (Leica Biosystems)
- Koninklijke Philips N.V.
- Olympus Corporation
- Hoffmann-La Roche Ltd.
- ContextVision AB
- Hamamatsu Photonics K.K.
- Mikroscan Technologies, Inc.
- Inspirata, Inc.
- Visiopharm A/S
- 3DHISTECH Ltd.
